| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Oasmia Pharmaceutical AB (publ) (ST: OASM)
OASM Technical Analysis
5
| As on 30th May 2022 OASM STOCK Price closed @ 1.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.19 & Strong Sell for SHORT-TERM with Stoploss of 3.86 we also expect STOCK to react on Following IMPORTANT LEVELS. |
OASMSTOCK Price
| Open | 1.02 | Change | Price | % |
| High | 1.06 | 1 Day | 0.01 | 1.00 |
| Low | 1.00 | 1 Week | -0.05 | -4.72 |
| Close | 1.01 | 1 Month | -0.65 | -39.16 |
| Volume | 741419 | 1 Year | -2.99 | -74.75 |
| 52 Week High 4.38 | 52 Week Low 1.00 | ||||
ST Sweden Most Active Stocks
| FING-B | 0.04 | 0.00% |
| QLINEA | 0.50 | 284.62% |
| HDW-B | 0.00 | % |
| LIPI | 0.25 | -7.41% |
| SBB-B | 4.91 | 0.61% |
| LUNE | 21.97 | 6.65% |
| WYLD | 0.01 | 0.00% |
| ENERS | 0.00 | % |
| KLAR | 0.61 | -8.96% |
| NIBE-B | 38.72 | -2.64% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| OASM Daily Charts |
OASM Intraday Charts |
Whats New @ Bazaartrend |
OASM Free Analysis |
|
|
OASM Important Levels Intraday
| RESISTANCE | 1.13 |
| RESISTANCE | 1.09 |
| RESISTANCE | 1.07 |
| RESISTANCE | 1.04 |
| SUPPORT | 0.98 |
| SUPPORT | 0.95 |
| SUPPORT | 0.93 |
| SUPPORT | 0.89 |
OASM Forecast January 2025
| 4th UP Forecast | 3.44 |
| 3rd UP Forecast | 2.66 |
| 2nd UP Forecast | 2.18 |
| 1st UP Forecast | 1.7 |
| 1st DOWN Forecast | 0.32 |
| 2nd DOWN Forecast | -0.16 |
| 3rd DOWN Forecast | -0.64 |
| 4th DOWN Forecast | -1.42 |
OASM Weekly Forecast
| 4th UP Forecast | 2.07 |
| 3rd UP Forecast | 1.73 |
| 2nd UP Forecast | 1.52 |
| 1st UP Forecast | 1.31 |
| 1st DOWN Forecast | 0.71 |
| 2nd DOWN Forecast | 0.50 |
| 3rd DOWN Forecast | 0.29 |
| 4th DOWN Forecast | -0.05 |
OASM Forecast2025
| 4th UP Forecast | 8.01 |
| 3rd UP Forecast | 5.76 |
| 2nd UP Forecast | 4.38 |
| 1st UP Forecast | 2.99 |
| 1st DOWN Forecast | -0.97 |
| 2nd DOWN Forecast | -2.36 |
| 3rd DOWN Forecast | -3.74 |
| 4th DOWN Forecast | -5.99 |
Oasmia Pharmaceutical AB (publ) ( ST Sweden Symbol : OASM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OASM Business Profile
Oasmia Pharmaceutical AB (publ) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. It focuses on manufacturing formulations based on cytostatics. The company offers Apealea/Paclical for the treatment of ovarian cancer. Its products portfolio includes Docetaxel micellar, a patented formulation that combines XR-17 with docetaxel that has completed pre-clinical trial for the treatment of prostate cancer; and Cantrixil, which has completed Phase I clinical trial for the treatment of ovarian cancer. The company also provides combination therapies, such as XR-19 for various forms of cancer, including ovarian, first-line breast, prostate, and lung cancer. In addition, its animal health product portfolio includes Paccal Vet, a patented formulation of paclitaxel for the treatment of mammary carcinoma; and Doxophos Vet, a patented formulation of doxorubicin for the treatment of lymphoma. Oasmia Pharmaceutical AB (publ) was incorporated in 1988 and is headquartered in Uppsala, Sweden. Address: Vallongatan 1, Uppsala, Sweden, 752 28
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service